The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of anti-EGFR and anti-VEGF antibodies on survival in BRAFV600E mutated metastatic colorectal cancer: A pooled analysis of eight clinical trials performed in the first-line treatment of mCRC (German AIO Study Group).
 
Lena Weiss
Honoraria - Roche; SERVIER
Consulting or Advisory Role - Roche
Research Funding - Illumina
Travel, Accommodations, Expenses - Amgen; Merck
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Servier (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Dominik Modest
Honoraria - 21up; Amgen; AstraZeneca; Bicara Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; IKF Klinische Krebsforschung; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; Rottapharm Biotech; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Cor2Ed; GlaxoSmithKline; Incyte; Lilly; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Ludwig von Weikersthal
No Relationships to Disclose
 
Arndt Stahler
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Takeda
Consulting or Advisory Role - Takeda
Research Funding - Merck KGaA (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Merck KGaA; Pfizer; Roche
 
Anke Reinacher-Schick
Honoraria - MCI Group; MSD; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Aurikamed; Boehringer Ingelheim; Daiichi Sankyo; MCI Deutschland; Pierre Fabre; Roche; Servier
Research Funding - AIO-Studien (Inst); BioNTech (Inst); Genentech (Inst); Georg-August-Universität Göttingen (UMG) (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MCI Deutschland; MSD; Pierre Fabre; Roche
 
Thomas Decker
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis
 
Victoria Probst
Travel, Accommodations, Expenses - Nordic Bioscience
 
Kathrin Heinrich
Honoraria - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche Pharma AG; SERVIER; Streamedup!; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Janssen; Merck KGaA; MSD (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Merck KGaA; SERVIER
(OPTIONAL) Uncompensated Relationships - DKG Krebsgesellschaft
 
Ingo Schwaner
Travel, Accommodations, Expenses - Abbvie; BeiGene; Janssen
 
Florian Kaiser
Consulting or Advisory Role - Abbvie; Astellas Pharma; Elsevier; Gilead Sciences; GlaxoSmithKline; Janssen; MSD; Novartis; Pierre Fabre; Sanofi; Sanofi; Servier
 
Rudolf Pihusch
No Relationships to Disclose
 
Martin Fuchs
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Annabel Alig
Honoraria - MSD
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Merck; Nordic Group; SERVIER
 
Birgit Gruenberger
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo Europe GmbH; Incyte; Lilly; Merck; MSD Oncology; Novartis; SERVIER; Takeda
 
Gerald Prager
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BMSi; Merck Serono; MSD; Pierre Fabre; Roche/Genentech; SERVIER; Taiho Oncology; Takeda
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; BMS; MSD; Novartis; Pierre Fabre; Sanofi; SERVIER; Takeda
Research Funding - BTG (Inst); Gilead Sciences (Inst); MSD (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pierre Fabre; Roche; SERVIER
 
Julien Taieb
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; BMS; Boehringer Ingelheim; Brenus Pharma; Merck KGaA; MSD; natera; Novartis; Pierre Fabre; PROSKOPE; sanofi; SERVIER; takeda
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; MSD; Novartis; Oncosil; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline; Halozyme; Janssen; Merck; MSD; Nordic Bioscience; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst); Servier (Inst)
Expert Testimony - Oncosil; Servier
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience